CH BIOTECH SER(08037): The investment agreement has expired.

CH BIOTECH SER (08037) announced that as of November 15, 2024, the conditions precedent had not been met (or waived), and the contracting parties had not reached an agreement to further extend the final deadline. Therefore, the investment agreement (supplemented by such supplemental agreements) has been declared null and void. The directors believe that the failure of the investment agreement will not have a significant adverse impact on the group's business, operations, and financial condition. As the investment agreement (supplemented by such supplemental agreements) has expired on November 15, 2024, the company will no longer send letters to shareholders regarding the investment agreement and the transactions proposed thereunder (including but not limited to investments and buyback rights) for reference.